Paul Winner

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

Stewart J. Tepper, Messoud Ashina, Uwe Reuter et al. · The Lancet Neurology · 2017 · 735 citations

Medicine, Neurology, Pharmacology +9

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

Tony W. Ho, Michel D. Ferrari, David W. Dodick et al. · The Lancet · 2008 · 529 citations

Medicine, Pharmacology, Pharmacotherapy +11

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program

Sheena K. Aurora, Paul Winner, Marshall C. Freeman et al. · Headache The Journal of Head and Face Pain · 2011 · 300 citations

Medicine, Pharmacology, Pharmacotherapy +17

A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents

Paul Winner, A. David Rothner, Joel R. Saper et al. · PEDIATRICS · 2000 · 281 citations

Pharmacy, Pharmacology, Pharmacotherapy +17